Advanced Glycation End Products Impair Glucose-Stimulated Insulin Secretion of a Pancreatic β-Cell Line INS-1-3 by Disturbance of Microtubule Cytoskeleton via p38/MAPK Activation

Advanced glycation end products (AGEs) are believed to be involved in diverse complications of diabetes mellitus. Overexposure to AGEs of pancreatic β-cells leads to decreased insulin secretion and cell apoptosis. Here, to understand the cytotoxicity of AGEs to pancreatic β-cells, we used INS-1-3 ce...

Full description

Saved in:
Bibliographic Details
Main Authors: Jia You, Zai Wang, Shiqing Xu, Wenjian Zhang, Qing Fang, Honglin Liu, Liang Peng, Tingting Deng, Jinning Lou
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2016/9073037
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850231587880304640
author Jia You
Zai Wang
Shiqing Xu
Wenjian Zhang
Qing Fang
Honglin Liu
Liang Peng
Tingting Deng
Jinning Lou
author_facet Jia You
Zai Wang
Shiqing Xu
Wenjian Zhang
Qing Fang
Honglin Liu
Liang Peng
Tingting Deng
Jinning Lou
author_sort Jia You
collection DOAJ
description Advanced glycation end products (AGEs) are believed to be involved in diverse complications of diabetes mellitus. Overexposure to AGEs of pancreatic β-cells leads to decreased insulin secretion and cell apoptosis. Here, to understand the cytotoxicity of AGEs to pancreatic β-cells, we used INS-1-3 cells as a β-cell model to address this question, which was a subclone of INS-1 cells and exhibited high level of insulin expression and high sensitivity to glucose stimulation. Exposed to large dose of AGEs, even though more insulin was synthesized, its secretion was significantly reduced from INS-1-3 cells. Further, AGEs treatment led to a time-dependent increase of depolymerized microtubules, which was accompanied by an increase of activated p38/MAPK in INS-1-3 cells. Pharmacological inhibition of p38/MAPK by SB202190 reversed microtubule depolymerization to a stabilized polymerization status but could not rescue the reduction of insulin release caused by AGEs. Taken together, these results suggest a novel role of AGEs-induced impairment of insulin secretion, which is partially due to a disturbance of microtubule dynamics that resulted from an activation of the p38/MAPK pathway.
format Article
id doaj-art-0b8a09594c0c45e19f0ca103f32dddef
institution OA Journals
issn 2314-6745
2314-6753
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-0b8a09594c0c45e19f0ca103f32dddef2025-08-20T02:03:28ZengWileyJournal of Diabetes Research2314-67452314-67532016-01-01201610.1155/2016/90730379073037Advanced Glycation End Products Impair Glucose-Stimulated Insulin Secretion of a Pancreatic β-Cell Line INS-1-3 by Disturbance of Microtubule Cytoskeleton via p38/MAPK ActivationJia You0Zai Wang1Shiqing Xu2Wenjian Zhang3Qing Fang4Honglin Liu5Liang Peng6Tingting Deng7Jinning Lou8Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, ChinaInstitute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, ChinaInstitute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, ChinaInstitute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, ChinaInstitute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, ChinaInstitute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, ChinaInstitute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, ChinaInstitute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, ChinaInstitute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, ChinaAdvanced glycation end products (AGEs) are believed to be involved in diverse complications of diabetes mellitus. Overexposure to AGEs of pancreatic β-cells leads to decreased insulin secretion and cell apoptosis. Here, to understand the cytotoxicity of AGEs to pancreatic β-cells, we used INS-1-3 cells as a β-cell model to address this question, which was a subclone of INS-1 cells and exhibited high level of insulin expression and high sensitivity to glucose stimulation. Exposed to large dose of AGEs, even though more insulin was synthesized, its secretion was significantly reduced from INS-1-3 cells. Further, AGEs treatment led to a time-dependent increase of depolymerized microtubules, which was accompanied by an increase of activated p38/MAPK in INS-1-3 cells. Pharmacological inhibition of p38/MAPK by SB202190 reversed microtubule depolymerization to a stabilized polymerization status but could not rescue the reduction of insulin release caused by AGEs. Taken together, these results suggest a novel role of AGEs-induced impairment of insulin secretion, which is partially due to a disturbance of microtubule dynamics that resulted from an activation of the p38/MAPK pathway.http://dx.doi.org/10.1155/2016/9073037
spellingShingle Jia You
Zai Wang
Shiqing Xu
Wenjian Zhang
Qing Fang
Honglin Liu
Liang Peng
Tingting Deng
Jinning Lou
Advanced Glycation End Products Impair Glucose-Stimulated Insulin Secretion of a Pancreatic β-Cell Line INS-1-3 by Disturbance of Microtubule Cytoskeleton via p38/MAPK Activation
Journal of Diabetes Research
title Advanced Glycation End Products Impair Glucose-Stimulated Insulin Secretion of a Pancreatic β-Cell Line INS-1-3 by Disturbance of Microtubule Cytoskeleton via p38/MAPK Activation
title_full Advanced Glycation End Products Impair Glucose-Stimulated Insulin Secretion of a Pancreatic β-Cell Line INS-1-3 by Disturbance of Microtubule Cytoskeleton via p38/MAPK Activation
title_fullStr Advanced Glycation End Products Impair Glucose-Stimulated Insulin Secretion of a Pancreatic β-Cell Line INS-1-3 by Disturbance of Microtubule Cytoskeleton via p38/MAPK Activation
title_full_unstemmed Advanced Glycation End Products Impair Glucose-Stimulated Insulin Secretion of a Pancreatic β-Cell Line INS-1-3 by Disturbance of Microtubule Cytoskeleton via p38/MAPK Activation
title_short Advanced Glycation End Products Impair Glucose-Stimulated Insulin Secretion of a Pancreatic β-Cell Line INS-1-3 by Disturbance of Microtubule Cytoskeleton via p38/MAPK Activation
title_sort advanced glycation end products impair glucose stimulated insulin secretion of a pancreatic β cell line ins 1 3 by disturbance of microtubule cytoskeleton via p38 mapk activation
url http://dx.doi.org/10.1155/2016/9073037
work_keys_str_mv AT jiayou advancedglycationendproductsimpairglucosestimulatedinsulinsecretionofapancreaticbcelllineins13bydisturbanceofmicrotubulecytoskeletonviap38mapkactivation
AT zaiwang advancedglycationendproductsimpairglucosestimulatedinsulinsecretionofapancreaticbcelllineins13bydisturbanceofmicrotubulecytoskeletonviap38mapkactivation
AT shiqingxu advancedglycationendproductsimpairglucosestimulatedinsulinsecretionofapancreaticbcelllineins13bydisturbanceofmicrotubulecytoskeletonviap38mapkactivation
AT wenjianzhang advancedglycationendproductsimpairglucosestimulatedinsulinsecretionofapancreaticbcelllineins13bydisturbanceofmicrotubulecytoskeletonviap38mapkactivation
AT qingfang advancedglycationendproductsimpairglucosestimulatedinsulinsecretionofapancreaticbcelllineins13bydisturbanceofmicrotubulecytoskeletonviap38mapkactivation
AT honglinliu advancedglycationendproductsimpairglucosestimulatedinsulinsecretionofapancreaticbcelllineins13bydisturbanceofmicrotubulecytoskeletonviap38mapkactivation
AT liangpeng advancedglycationendproductsimpairglucosestimulatedinsulinsecretionofapancreaticbcelllineins13bydisturbanceofmicrotubulecytoskeletonviap38mapkactivation
AT tingtingdeng advancedglycationendproductsimpairglucosestimulatedinsulinsecretionofapancreaticbcelllineins13bydisturbanceofmicrotubulecytoskeletonviap38mapkactivation
AT jinninglou advancedglycationendproductsimpairglucosestimulatedinsulinsecretionofapancreaticbcelllineins13bydisturbanceofmicrotubulecytoskeletonviap38mapkactivation